Profile of Linzagolix in the Management of Endometriosis, Including Design, Development and Potential Place in Therapy: A Narrative Review

References

• Donnez J. The heterogeneity of endometriotic lesions could be explained by their progesterone resistance. Hum Reprod. 2021;36(9):2624–2625. doi:10.1093/humrep/deab151
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. Endometriosis and medical therapy: from progestogens to progesterone resistance to GnRH antagonists: a review. J Clin Med. 2021;10(5):1085. doi:10.3390/jcm10051085
   PubMed Web of Science ®Google Scholar
• Cacciottola L, Donnez J, Dolmans MM. Can endometriosis-related oxidative stress pave the way for new treatment targets? Int J Mol Sci. 2021;22(13):7138. doi:10.3390/ijms22137138
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM. GnRH antagonists with or without add-back therapy: a new alternative in the management of endometriosis? Int J Mol Sci. 2021;22(21):11342. doi:10.3390/ijms222111342
   PubMed Web of Science ®Google Scholar
• Soliman AM, Rahal Y, Robert C, et al. Impact of endometriosis on fatigue and productivity impairment in a cross-sectional survey of Canadian women. J Obstet Gynaecol Can. 2021;43(1):10–18. doi:10.1016/j.jogc.2020.06.022
   PubMed Web of Science ®Google Scholar
• Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril. 2011;96(2):366–373.e8. doi:10.1016/j.fertnstert.2011.05.090
   PubMed Web of Science ®Google Scholar
• Vercellini P, Donati A, Ottolini F, et al. A stepped-care approach to symptomatic endometriosis management: a participatory research initiative. Fertil Steril. 2018;109(6):1086–1096. doi:10.1016/j.fertnstert.2018.01.037
   PubMed Web of Science ®Google Scholar
• Vercellini P, Buggio L, Frattaruolo MP, Borghi A, Dridi D, Somigliana E. Medical treatment of endometriosis-related pain. Best Pract Res Clin Obstet Gynaecol. 2018;51:68–91. doi:10.1016/j.bpobgyn.2018.01.015
   PubMed Web of Science ®Google Scholar
• Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril. 2017;107(3):533–536. doi:10.1016/j.fertnstert.2017.01.003
   PubMed Web of Science ®Google Scholar
• Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil Steril. 1997;68(4):585–596. doi:10.1016/S0015-0282(97)00191-X
   PubMed Web of Science ®Google Scholar
• Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis. Endocr Rev. 2019;40(4):1048–1079. doi:10.1210/er.2018-00242
   PubMed Web of Science ®Google Scholar
• Bulun SE, Cheng YH, Pavone ME, et al. 17Beta-hydroxysteroid dehydrogenase-2 deficiency and progesterone resistance in endometriosis. Semin Reprod Med. 2010;28(1):44–50. doi:10.1055/s-0029-1242992
   PubMed Web of Science ®Google Scholar
• Yilmaz BD, Bulun SE. Endometriosis and nuclear receptors. Hum Reprod Update. 2019;25(4):473–485. doi:10.1093/humupd/dmz005
   PubMed Web of Science ®Google Scholar
• Donnez J, Cacciottola L. Endometriosis: an inflammatory disease that requires new therapeutic options. Int J Mol Sci. 2022;23(3):1518. doi:10.3390/ijms23031518
   PubMed Web of Science ®Google Scholar
• Barbara G, Buggio L, Facchin F, Vercellini P. Medical treatment for endometriosis: tolerability, quality of life and adherence. Front Glob Womens Health. 2021;2:729601. doi:10.3389/fgwh.2021.729601
   PubMedGoogle Scholar
• Pohl O, Baron K, Riggs M, French J, Garcia R, Gotteland JP. A model-based analysis to guide gonadotropin-releasing hormone receptor antagonist use for management of endometriosis. Br J Clin Pharmacol. 2022;88(5):2359–2371. doi:10.1111/bcp.15171
   PubMed Web of Science ®Google Scholar
• Donnez J, Taylor RN, Taylor HS. Partial suppression of estradiol: a new strategy in endometriosis management? Fertil Steril. 2017;107(3):568–570. doi:10.1016/j.fertnstert.2017.01.013
   PubMed Web of Science ®Google Scholar
• Donnez J, Taylor HS, Taylor RN, et al. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial. Fertil Steril. 2020;114(1):44–55. doi:10.1016/j.fertnstert.2020.02.114
   PubMed Web of Science ®Google Scholar
• Lamb YN. Elagolix: first global approval. Drugs. 2018;78(14):1501–1508. doi:10.1007/s40265-018-0977-4
   PubMed Web of Science ®Google Scholar
• Markham A. Relugolix: first global approval. Drugs. 2019;79(6):675–679. doi:10.1007/s40265-019-01105-0
   PubMed Web of Science ®Google Scholar
• Yselty. European medicines agency (Europa.eu); 2012.
   Google Scholar
• Pohl O, Marchand L, Bell D, Gotteland JP. Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding-delayed add-back onset does not improve bleeding pattern. Reprod Sci. 2020;27(4):988–995. doi:10.1007/s43032-020-00172-z
   PubMed Web of Science ®Google Scholar
• Tezuka M, Tamai Y, Kuramochi Y, Kobayashi K, Fushimi N, Kiguchi S. Pharmacological characterization of linzagolix, a novel, orally active, non-peptide antagonist of gonadotropin-releasing hormone receptors. Clin Exp Pharmacol Physiol. 2022;49(10):1082–1093. doi:10.1111/1440-1681.13688
   PubMed Web of Science ®Google Scholar
• Taylor H, Gemzell-Danielsson K. Linzagolix for endometriosis-associated pain: efficacy results from Edelweiss 3, a phase 3, randomized, double blind, placebo-controlled trial Abstract presented at the 8th Annual Meeting of SEUD; 2022.
   Google Scholar
• Donnez J, Taylor H, Gemzell-Danielsson H, et al. O-306 Linzagolix for endometriosis-associated pain: safety results from Edelweiss 3, a phase 3, randomized, double-blind, placebo-controlled trial. Hum Reprod. 2022;37(Supplement_1):deac105. doi:10.1093/humrep/deac105.103
   Google Scholar
• Barbieri RL. Hormone treatment of endometriosis: the estrogen threshold hypothesis. Am J Obstet Gynecol. 1992;166(2):740–745. doi:10.1016/0002-9378(92)91706-G
   PubMed Web of Science ®Google Scholar
• Lessey BA, Gordts S, Donnez O, et al. Ovarian endometriosis and infertility: in vitro fertilization (IVF) or surgery as the first approach? Fertil Steril. 2018;110(7):1218–1226. doi:10.1016/j.fertnstert.2018.10.003
   PubMed Web of Science ®Google Scholar
• Donnez J. Women with endometrioma-related infertility face a dilemma when choosing the appropriate therapy: surgery or in vitro fertilization. Fertil Steril. 2018;110(7):1216–1217. doi:10.1016/j.fertnstert.2018.10.002
   PubMed Web of Science ®Google Scholar
• Kitajima M, Defrère S, Dolmans MM, et al. Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril. 2011;96(3):685–691. doi:10.1016/j.fertnstert.2011.06.064
   PubMed Web of Science ®Google Scholar
• Kitajima M, Dolmans MM, Donnez O, Masuzaki H, Soares M, Donnez J. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101(4):1031–1037. doi:10.1016/j.fertnstert.2013.12.049
   PubMed Web of Science ®Google Scholar
• Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis. Hum Reprod Open. 2022;2022(2):hoac009. doi:10.1093/hropen/hoac009
   PubMedGoogle Scholar
• Capezzuoli T, Vannuccini S, Mautone D, et al. Long-term hormonal treatment reduces repetitive surgery for endometriosis recurrence. Reprod Biomed Online. 2021;42(2):451–456. doi:10.1016/j.rbmo.2020.09.018
   PubMed Web of Science ®Google Scholar
• Donnez O, Donnez J. Deep endometriosis: the place of laparoscopic shaving. Best Pract Res Clin Obstet Gynaecol. 2021;71:100–113. doi:10.1016/j.bpobgyn.2020.05.006
   PubMed Web of Science ®Google Scholar
• Koninckx PR, Ussia A, Adamyan L, Wattiez A, Gomel V, Martin DC. Pathogenesis of endometriosis: the genetic/epigenetic theory. Fertil Steril. 2019;111(2):327–340. doi:10.1016/j.fertnstert.2018.10.013
   PubMed Web of Science ®Google Scholar
• Donnez O, Orellana R, Van Kerk O, Dehoux JP, Donnez J, Dolmans MM. Invasion process of induced deep nodular endometriosis in an experimental baboon model: similarities with collective cell migration? Fertil Steril. 2015;104(2):491–7.e2. doi:10.1016/j.fertnstert.2015.05.011
   PubMed Web of Science ®Google Scholar
• Koninckx PR, Ussia A, Adamyan L, Wattiez A, Donnez J. Deep endometriosis: definition, diagnosis, and treatment. Fertil Steril. 2012;98(3):564–571. doi:10.1016/j.fertnstert.2012.07.1061
   PubMed Web of Science ®Google Scholar
• Reis FM, Coutinho LM, Vannuccini S, Batteux F, Chapron C, Petraglia F. Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure. Hum Reprod Update. 2020;26(4):565–585. doi:10.1093/humupd/dmaa009
   PubMed Web of Science ®Google Scholar
• Soliman AM, Yang H, Du EX, Kelley C, Winkel C. The direct and indirect costs associated with endometriosis: a systematic literature review. Hum Reprod. 2016;31(4):712–722. doi:10.1093/humrep/dev335
   PubMed Web of Science ®Google Scholar
• Soliman AM, Surrey E, Bonafede M, Nelson JK, Castelli-Haley J. Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States. Adv Ther. 2018;35(3):408–423. doi:10.1007/s12325-018-0667-3
   PubMed Web of Science ®Google Scholar